Ben-Meir, A, Burstein, E, Borrego-Alvarez, A, et al. (2015) Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 14: 887–895.
Bourgain, C, Devroey, P (2003) The endometrium in stimulated cycles for IVF. Human Reproduction Update 9(6): 515–522.
Brinsden, P (2005) Superovulation strategies in assisted conception. In: Brinsden, P (ed.) A Textbook of In Vitro Fertilization and Assisted Reproduction, 3rd edn. Taylor-Francis, London, pp. 177–188.
Broer, SL, Dólleman, M, Opmeer, BC, et al. (2011) AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human Reproduction Update 17(1): 46–54.
Cai, J, Lou, H-Y, Dong, M-Y, et al. (2007) Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Fertility and Sterility 87(6): 1350–1356.
Cargill, M, Altshuler, D, Ireland, J, et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics 22: 231–238.
Chang, EM, Song, HS, Lee, DR, et al. (2014) In vitro maturation of human oocytes: its role in infertility treatment and new possibilities. Clinical Experiments in Reproductive Medicine 41(2): 41–46.
Chian, RC, Cao, YX (2014) In vitro maturation of immature human oocytes for clinical application. Methods in Molecular Biology 1154: 271–288.
Conway, GS (1996) Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clinical Endocrinology 45: 657–663.
Cortvrindt, R, Smitz, J, Van Steirteghem, AC (1997) Assessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Human Reproduction 12: 759–768.
Desai, AS, Achrekar, AK, Paranjape, SR, et al. (2013) Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reproductive BioMedicine Online 27: 400–406.
Devroey, P, Boostanfar, R, Koper, NP, Mannaerts, BM, Ijzerman-Boon, PC, Fauser, BC (2009) A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Human Reproduction 24: 3063–3072.
Durlinger, AL, Gruijters, MJ, Kramer, P, et al. (2001) Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142: 4891–4899.
Fanchin, R, Louafi, N, Mendez Lozano, DH, Frydman, N, Frydman, R, Taieb, J (2005) Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertility and Sterility 84: 167–173.
Fowler, RE, Edwards, RG (1957) Induction of superovulation and pregnancy in mature mice by gonadotrophins. Journal of Endocrinology 15: 374–384.
Hillier, SG (1991) Regulatory functions for inhibin and activin in human ovaries. Journal of Endocrinology 131: 171–175.
Hillier, SG (2009) The science of ovarian ageing: How might knowledge be translated into practice? In: Bewley, S, Ledger, W, Nikolaou, D (eds.) Reproductive Ageing. RCOG Press, London, pp. 75–87.
Howles, CM, Macnamee, MC, Edwards, RG (1987) Follicular development and early luteal function of conception and non-conceptual cycles after human in vitro fertilization. Human Reproduction 2: 17–21.
Howles, CM, Macnamee, MC, Edwards, RG, Goswamy, R, Steptoe, PC (1986) Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilization. Lancet 2: 521–522.
Kevenaar, ME, Themmen, AP, Laven, JS, et al. (2007) Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Human Reproduction 22: 1547–1554.
Kumar, TR, Wang, Y, Lu, N, Matzuk, MM (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nature Genetics 15: 201–203.
La Marca, A, De Leo, V, Giulini, S, et al. (2005) Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. Journal of the Society for Gynecological Investigation 12(7): 545–548.
La Marca, A, Malmusi, S, Giulini, S, et al. (2004) Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Human Reproduction 19(12): 2738–2741.
La Marca, A, Sighinolfi, G, Radi, D, et al. (2010) Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology. Human Reproduction Update 16(2): 113–130.
La Marca, A, Stabile, G, Artenisio, AC, Volpe, A (2006) Serum anti-Müllerian hormone throughout the human menstrual cycle. Human Reproduction 21: 3103–3107.
Lamminen, T, Huhtaniemi, I (2001) A common genetic variant of luteinizing hormone: relation to normal and aberrant pituitary-gonadal function. European Journal of Pharmacology 414: 1–7.
Loumaye, E, Engrand, P, Howles, CM, O’Dea, L (1997) Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization outcome. Fertility and Sterility 67: 889–899.
Macnamee, MC, Howles, CM, Edwards, RG, et al. (1989) Short term luteinising hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilisation. Fertility and Sterility 52: 264–269.
Nilsson, E, Rogers, N, Skinner, MK (2007) Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 134(2): 209–221.
Oudshoom, SC, van Tilborg, TC, Eijkemans, MJC, et al. (2017) Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder. Human Reproduction 32(12): 2506–2514.
Perez-Mayorga, M, Gromoll, J, Behre, HM, et al. (2000). Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. Journal of Clinical Endocrinology and Metabolism 85(9): 3365–3369.
Pigny, P, Jonard, S, Robert, Y, Dewailly, D (2006) Serum Anti-Müllerian Hormone as a surrogate for antral follicle count for definition of the Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism 91: 941–945.
Regan, L, Owen, EJ, Jacobs, HS (1990) Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336: 1141–1144.
Shenfield, F (1996) FSH: what is its role in infertility treatments, and particularly in IVF? Medical Dialogue 471: 1–4.
Silvestris, E, Cohen, M, Cornet, D, et al. (2017) Supporting the One-Carbon Cycle restores ovarian reserve in subfertile women: absence of correlation with urinary Bisphenol A concentration. BioResearch Open Access 6(1). DOI: 10.1089/biores.2017.0016.
Simoni, M, Nieschlag, E, Gromoll, J (2002) Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Human Reproduction Update 8(5): 413–421.
Steiner, AZ, Pritchard, D, Stanczyk, FZ, et al. (2017) Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. Journal of the American Medical Association 318(14): 1367–1376.
Su, HI, Sammel, MD, Freeman, EW, et al. (2008) Body size affects measures of ovarian reserve in late reproductive age women. Menopause 15: 857–861.
Tavaniotou, A, Smitz, J, Bourgain, C, Devroey, P (2001) Ovulation induction disrupts luteal phase function. Annals of the New York Academy of Sciences 943: 55–63.
Telfer, EE (1996) The development of methods for isolation and culture of preantral follicles from bovine and porcine ovaries. Theriogenology 45: 101–110.
Tohlob, D, Hshem, EA, Gharreb, N, et al. (2016) Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatment. Reproductive BioMedicine Online 33: 391–397.
Tournaye, H, Sukhikh, GT, Kahler, E, Griesinger, G (2017) A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human Reproduction 32(5): 1019–1027.
Ulug, U, Ben-Shlomo, I, Turan, E, Erden, HF, Akman, MA, Bahceci, M (2003) Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reproductive BioMedicine Online 6: 439–443.
Visser, JA, Themmen, AP (2005) Anti-Müllerian hormone and folliculogenesis. Molecular and Cellular Endocrinology 234: 81–86.
Webber, LJ, Stubbs, S, Stark, J, et al. (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362: 1017–1021.
Weenen, C, Laven, JS, Von Bergh, AR, et al. (2004) Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 10: 77–83.
Wunder, DM, Bersinger, NA, Yared, M, Kretschmer, R, Birkhauser, MH (2008). Statistically significant changes of anti-mullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertility and Sterility 89: 927–933.